Figure 2
Figure 2. Erythrocyte glutamine depletion in sickle cell disease and its association with pulmonary hypertension. (A) Erythrocyte glutamine levels in healthy volunteers were similar to SCD patients without pulmonary hypertension (No PH, n = 23). However, glutamine levels were significantly decreased in SCD patients with a tricuspid regurgitant jet velocity (TRV) of at least 2.5 m/s on Doppler echocardiography (PH, n = 17) compared with SCD patients without PH (P < .001) and (B) erythrocyte glutamine levels inversely correlated with TRV on Doppler echocardiography (r = -0.51, P < .0001). (C) A significant reduction in the erythrocyte glutamine:glutamate ratio is identified in SCD compared with controls, with the lowest ratios identified in patients with PH. (D) The glutamine:glutamate ratio inversely correlated with TRV on Doppler echocardiography (r = −0.62, P < .001, Figure 2D), implicating glutamine bioavailability as a novel factor in the pathophysiology of PH.

Erythrocyte glutamine depletion in sickle cell disease and its association with pulmonary hypertension. (A) Erythrocyte glutamine levels in healthy volunteers were similar to SCD patients without pulmonary hypertension (No PH, n = 23). However, glutamine levels were significantly decreased in SCD patients with a tricuspid regurgitant jet velocity (TRV) of at least 2.5 m/s on Doppler echocardiography (PH, n = 17) compared with SCD patients without PH (P < .001) and (B) erythrocyte glutamine levels inversely correlated with TRV on Doppler echocardiography (r = -0.51, P < .0001). (C) A significant reduction in the erythrocyte glutamine:glutamate ratio is identified in SCD compared with controls, with the lowest ratios identified in patients with PH. (D) The glutamine:glutamate ratio inversely correlated with TRV on Doppler echocardiography (r = −0.62, P < .001, Figure 2D), implicating glutamine bioavailability as a novel factor in the pathophysiology of PH.

Close Modal

or Create an Account

Close Modal
Close Modal